BIVALIRUDIN 250 mg/1
BIVALIRUDIN · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Eugia US LLC
No Recall History
Plain English
BIVALIRUDIN is a injection, powder, lyophilized, for solution containing bivalirudin at 250 mg/1, taken intravenous. Manufactured by Eugia US LLC.
Key Facts
- Brand Name
- BIVALIRUDIN
- Generic Name
- BIVALIRUDIN
- NDC Code (Product)
55150-210- Manufacturer
- Eugia US LLC
- Strength
- 250 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- ANDA205962
- Drug Class
- Anti-coagulant [EPC]; Direct Thrombin Inhibitor [EPC]
- Marketing Start
- 07/27/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is BIVALIRUDIN used for?
BIVALIRUDIN contains BIVALIRUDIN. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is BIVALIRUDIN a controlled substance?
BIVALIRUDIN is not classified as a controlled substance by the DEA.
What is the generic name for BIVALIRUDIN?
The generic name for BIVALIRUDIN is BIVALIRUDIN. There are 10 other brand versions of BIVALIRUDIN.
What is the NDC code for BIVALIRUDIN 250 mg/1?
The NDC (National Drug Code) for BIVALIRUDIN 250 mg/1 is 55150-210, listed by Eugia US LLC.